Hugging Face's logo
13's picture

13

Qozimo
10 3
peterleeishere's profile picture
·

AI & ML interests

None yet

Recent Activity

repliedto ProCreations's post 18 minutes ago
I have hit 300 followers, and I think this calls for a bit of a giveaway 👀 a unique one, too. I have had countless AI projects I have wanted to make but have been (brutally) blocked by compute. Now that I finally have just enough compute to sort of get around (i still don't have enough 😭) and for hitting 300 followers (tysm!) I will be funding three of the communities projects via HuggingFace jobs, giving them 150 dollars max worth of compute each. I will personally be picking the winners, I am looking for projects that genuinely hit the compute wall: great ideas, blocked by compute, just like the countless ideas I've had. To join, head over to https://giveaway.ssh.codes RULES: - Final result must be open weight or open source - Only one submission per person - Have fun!
repliedto ProCreations's post about 2 hours ago
I have hit 300 followers, and I think this calls for a bit of a giveaway 👀 a unique one, too. I have had countless AI projects I have wanted to make but have been (brutally) blocked by compute. Now that I finally have just enough compute to sort of get around (i still don't have enough 😭) and for hitting 300 followers (tysm!) I will be funding three of the communities projects via HuggingFace jobs, giving them 150 dollars max worth of compute each. I will personally be picking the winners, I am looking for projects that genuinely hit the compute wall: great ideas, blocked by compute, just like the countless ideas I've had. To join, head over to https://giveaway.ssh.codes RULES: - Final result must be open weight or open source - Only one submission per person - Have fun!
repliedto SeaWolf-AI's post 3 days ago
🧬 Your AI can design a malaria drug candidate. Can it tell you whether it's any good? Open Discovery Challenge #1 — Malaria is live. Design a molecule with any model — OpenAI, Claude, Gemini, Qwen, KIMI, DeepSeek, open weights, or by hand — submit it as SMILES, and it's scored in minutes on whole-cell activity, target binding, selectivity over the human enzyme, ADMET, novelty and synthesisability. You can check the scoring instead of trusting it. Approved drugs sit on the same leaderboard as the entries: DSM265, a clinical-stage antimalarial, scores 50.9. Teriflunomide — approved, but it hits the human enzyme — scores 2.8. Caffeine scores 1.8. If the clinical candidate lands on top and coffee lands at the bottom, the scorer discriminates. We caught 14 defects before opening — conventional toxicity cutoffs rejected all three approved antimalarials and coffee. All written up, along with the rule we now hold everything to: a gate that rejects an approved drug is a broken gate. Your molecule stays yours. No patent interest, nothing into our pipeline. You choose whether it's published — and publishing can cost you patentability, so we say so. USD 1,000 to the top entry when Season #1 closes 30 September 2026 — not payment for your tokens, but a way of saying the work had worth. Malaria killed ~597,000 people in 2023, three quarters of them children under five. Not for want of chemistry — for want of a market. No chemistry needed: the guide ships five prompts you can paste straight into your model, and the full rubric is published. 📖 https://huggingface.co/blog/FINAL-Bench/open-discovery-challenge 🚀 https://huggingface.co/spaces/FINAL-Bench/open-discovery-challenge Computational assessments of candidates — not measurements, not claims of efficacy.
View all activity

Organizations

None yet